Inhalation and Nasal Spray Generic Drugs Market to Rise Thanks to Enhanced Efficiency and Better Compliance of Combination Drugs
The increasing occurrence of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, and the soaring count of generic manufacturers are amongst the prime factors fuelling the growth inhalation and nasal spray generic drugs market. In terms of drug class, the market is segmented into corticosteroids, bronchodilators, antihistamines, combinations, and decongestant sprays.
View full press release